Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Prognostic significance of total disease length in esophageal cancer.

Davies L, Mason JD, Roberts SA, Chan D, Reid TD, Robinson M, Gwynne S, Crosby TD, Lewis WG.

Surg Endosc. 2012 Oct;26(10):2810-6. Epub 2012 Apr 26.

PMID:
22534739
2.

Prognostic significance of the endoscopic ultrasound defined lymph node metastasis count in esophageal cancer.

Twine CP, Roberts SA, Rawlinson CE, Davies L, Escofet X, Dave BV, Crosby TD, Lewis WG.

Dis Esophagus. 2010 Nov;23(8):652-9. doi: 10.1111/j.1442-2050.2010.01072.x.

PMID:
20545976
3.

Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.

Griffin JM, Reed CE, Denlinger CE.

Ann Thorac Surg. 2012 Jun;93(6):1855-9; discussion 1860. doi: 10.1016/j.athoracsur.2011.12.095. Epub 2012 Apr 18.

PMID:
22516835
4.

Treatment of clinical T2N0M0 esophageal cancer.

Hardacker TJ, Ceppa D, Okereke I, Rieger KM, Jalal SI, LeBlanc JK, DeWitt JM, Kesler KA, Birdas TJ.

Ann Surg Oncol. 2014 Nov;21(12):3739-43. doi: 10.1245/s10434-014-3929-6. Epub 2014 Jul 22.

PMID:
25047477
5.

[Esophageal cancer: outcome according to therapeutic strategy].

Rousseau D, Capitain O, Denis F, Girault S, Poirier AL, Paumier A, Cellier P, Hamy A, Mahé MA, Mesgouez-Nebout N.

Cancer Radiother. 2013 Feb;17(1):10-20. doi: 10.1016/j.canrad.2012.10.011. Epub 2012 Dec 25. French.

PMID:
23270680
6.

Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer.

Twine CP, Roberts SA, Lewis WG, Dave BV, Rawlinson CE, Chan D, Robinson M, Crosby TD.

Surg Endosc. 2010 Apr;24(4):870-8. doi: 10.1007/s00464-009-0681-2.

PMID:
19730945
7.

Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma.

Morgan MA, Lewis WG, Casbard A, Roberts SA, Adams R, Clark GW, Havard TJ, Crosby TD.

Br J Surg. 2009 Nov;96(11):1300-7. doi: 10.1002/bjs.6705.

PMID:
19847875
8.

Accuracy of PET-CT in predicting survival in patients with esophageal cancer.

Brown C, Howes B, Jamieson GG, Bartholomeusz D, Zingg U, Sullivan TR, Thompson SK.

World J Surg. 2012 May;36(5):1089-95. doi: 10.1007/s00268-012-1470-y.

PMID:
22374537
9.

Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.

Matsuda S, Tsubosa Y, Niihara M, Sato H, Takebayashi K, Kawamorita K, Mori K, Tsushima T, Yokota T, Ogawa H, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y.

Ann Surg Oncol. 2015;22(6):1866-73. doi: 10.1245/s10434-014-4337-7. Epub 2015 Jan 7.

PMID:
25564176
10.

Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma.

Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA.

Cancer. 2005 Oct 15;104(8):1620-6.

11.

Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.

Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K.

Ann Surg Oncol. 2013 Sep;20(9):3038-43. doi: 10.1245/s10434-013-2988-4. Epub 2013 Apr 28.

PMID:
23625142
12.

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.

Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.

Ann Thorac Surg. 2004 Oct;78(4):1152-60; discussion 1152-60. Review.

PMID:
15464463
13.

Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.

Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E.

Ann Surg Oncol. 2011 Dec;18(13):3743-54. doi: 10.1245/s10434-011-1753-9. Epub 2011 May 10.

PMID:
21556952
14.

Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.

Reid TD, Davies IL, Mason J, Roberts SA, Crosby TD, Lewis WG.

Clin Oncol (R Coll Radiol). 2012 Nov;24(9):617-24. doi: 10.1016/j.clon.2012.02.001. Epub 2012 Mar 3.

PMID:
22386923
15.

Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer.

Watanabe M, Baba Y, Yoshida N, Ishimoto T, Nagai Y, Iwatsuki M, Iwagami S, Baba H.

Ann Surg Oncol. 2014 Sep;21(9):2838-44. doi: 10.1245/s10434-014-3684-8. Epub 2014 Apr 9.

PMID:
24715216
16.

Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation.

Jeene PM, Versteijne E, van Berge Henegouwen MI, Bergmann JJ, Geijsen ED, van Laarhoven HW, Hulshof MC.

Acta Oncol. 2017 Jan;56(1):33-38. doi: 10.1080/0284186X.2016.1240880. Epub 2016 Nov 15.

PMID:
27842455
17.

N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?

Foley KG, Lewis WG, Fielding P, Karran A, Chan D, Blake P, Roberts SA.

Clin Radiol. 2014 Sep;69(9):959-64. doi: 10.1016/j.crad.2014.04.023. Epub 2014 Jun 7.

PMID:
24916652
18.

A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.

Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA.

Eur J Cancer. 2012 Dec;48(18):3396-404. doi: 10.1016/j.ejca.2012.06.020. Epub 2012 Jul 31.

19.

Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.

Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K.

Ann Surg Oncol. 2014 Nov;21(12):3744-50. doi: 10.1245/s10434-014-3795-2. Epub 2014 May 23.

PMID:
24854492
20.

Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.

Dittrick GW, Weber JM, Shridhar R, Hoffe S, Melis M, Almhanna K, Barthel J, McLoughlin J, Karl RC, Meredith KL.

Ann Surg Oncol. 2012 May;19(5):1678-84. doi: 10.1245/s10434-011-2078-4. Epub 2011 Nov 2.

PMID:
22045465

Supplemental Content

Support Center